J. Goldman & Co LP - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 148 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$3,118,500
-25.9%
13,500
-22.3%
0.11%
-33.5%
Q1 2023$4,208,298
+36.9%
17,371
-63.3%
0.17%
+15.6%
Q3 2022$3,074,000
+481.1%
47,300
+944.6%
0.15%
+539.1%
Q1 2018$529,0004,5280.02%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
HealthCor Management, L.P. 1,402,250$93,614,0004.00%
Parkman Healthcare Partners LLC 30,000$2,003,0000.93%
ARMISTICE CAPITAL, LLC 216,000$14,420,0000.89%
Avoro Capital Advisors LLC 349,000$23,299,0000.79%
Rock Springs Capital Management LP 250,000$16,690,0000.69%
Capital Impact Advisors, LLC 24,351$1,626,0000.68%
Baker Brothers Advisors 1,499,212$100,087,0000.62%
EWG Elevate Inc. 11,086$740,0000.56%
SHIKIAR ASSET MANAGEMENT INC 12,000$801,0000.54%
DAFNA Capital Management LLC 13,600$908,0000.38%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders